AXALBION THERAPEUTICS LIMITED

13224059
Active Altrincham

Manufacture of basic pharmaceutical products

7 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
A

AXALBION THERAPEUTICS LIMITED

13224059

Manufacture of basic pharmaceutical products

Founded 24 Feb 2021 Active Altrincham, United Kingdom 7 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 20 May 2026 Next due 30 Sept 2026 2 months remaining
Confirmation Submitted 29 May 2026 Next due 29 May 2027 10 months remaining
Net assets £8M £5M 2024 year on year
Total assets £11M £6M 2024 year on year
Total Liabilities £2M £1M 2024 year on year
Charges 2
2 satisfied

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom

Email

info@example.com

Website

www.example.com

Full company profile for AXALBION THERAPEUTICS LIMITED (13224059), an active life sciences and medical technology company based in Altrincham, United Kingdom. Incorporated 24 Feb 2021. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 2 months remaining

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£5.03M

Increased by £4.90M (+3829%)

Net Assets

£8.31M

Increased by £4.75M (+133%)

Total Liabilities

£2.45M

Increased by £1.31M (+116%)

Turnover

N/A

Employees

7

Debt Ratio

23%

Decreased by 1 (-4%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2

Investors (4)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jul 2018Seed
Investor 2Jul 2018Seed
Investor 3Aug 2024Unknown/Other

Share Capital

Share Capital

Share allotments and capital structure

12 Allotments 2,228,108 Shares £14.13m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Jul 202522,926£330k£14.38
4 Nov 2024181,433£2.09m£11.5
5 Apr 202481,392£276k£3.393
5 Apr 202489,600£9k£0.1
5 Apr 2024102,890£823k£8

Officers

Officers

2 active 1 resigned
Status
Glyer, Paul HartleyDirectorAmericanUnited States6916 Mar 2021Active
Woodcock, Ashley Arthur, ProfessorDirectorBritishEngland7524 Feb 2021Active

Shareholders

Shareholders (22)

Moulton Goodies Limited
42.6%
1,088,268
Seaward Partners 1 L.p
16.4%
417,639

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Jonathan Paul Moulton

British

Active
Notified 16 Mar 2021
Residence United Kingdom
DOB October 1950
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Professor Ashley Arthur Woodcock

Ceased 16 Mar 2021

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

2 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 May 2026Confirmation StatementConfirmation statement made on 15 May 2026 with updates
20 May 2026AccountsAnnual accounts made up to 31 Dec 2025
19 Dec 2025OfficersTermination of Michael Kitt as director on 19 Dec 2025
26 Sept 2025AccountsAnnual accounts made up to 31 Dec 2024
28 Jul 2025AddressChange Registered Office Address Company With Date Old Address New Address
29 May 2026 Confirmation Statement

Confirmation statement made on 15 May 2026 with updates

20 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

19 Dec 2025 Officers

Termination of Michael Kitt as director on 19 Dec 2025

26 Sept 2025 Accounts

Annual accounts made up to 31 Dec 2024

28 Jul 2025 Address

Change Registered Office Address Company With Date Old Address New Address

Recent Activity

Latest Activity

Confirmation statement made on 15 May 2026 with updates

1 months ago on 29 May 2026

Annual accounts made up to 31 Dec 2025

1 months ago on 20 May 2026

Termination of Michael Kitt as director on 19 Dec 2025

6 months ago on 19 Dec 2025

Annual accounts made up to 31 Dec 2024

9 months ago on 26 Sept 2025

Change Registered Office Address Company With Date Old Address New Address

11 months ago on 28 Jul 2025